Student hosts book drive to benefit Center for Homeless

Senior Bridget Meade looks to harness the power of the written word, fighting poverty with the power of fairytales and nursery rhymes. Meade is hosting a book drive at Saint Mary’s to create a preschool library at the South Bend Center for the Homeless. “Reading can be both enjoyable and powerful. Education is such a great way to fight poverty, and reading is one of the best ways to educate children,” she said. Meade is the founder of Mommy and Me, a literacy class at the Center. The program encourages and teaches parents to read to their children. The library will be made available to both the students in her class and other guests at the Center, she said. Meade said she was inspired to create this class because of her own love of reading. “Reading was such a huge part of my childhood that I thought it was a tragedy that some kids aren’t being read to,” she said. Reading is a beneficial activity for both children and parents living in poverty, Meade said. The Mommy and Me class will help parents learn to enjoy reading to their children. “Many parents in poverty were not read to as children, which makes it uncomfortable for them to read to their own children,” she said. The Mommy and Me class teaches parents reading to infants and toddlers is a powerful activity, benefitting a child’s cognitive development and overall life trajectory, Meade said. Some parents living at the Center are illiterate and too uncomfortable to read to their children, she said. The preschool library will provide illiterate parents picture books. Those parents can still read and interact with their children by creating stories based off the illustrations, she said, something crucial to their maturation. “Reading to preschoolers is about helping them interact and hear words that will help with their cognitive development,” Meade said. Meade said preschoolers enjoy classic fairy tales and nursery rhymes the most. “The best books to donate are the old school classics,” she said. Books will be accepted at a drop box in LeMans Hall through the end of the year, or contact Bridget Meade with questions about the book drive at bmeade01@saintmarys.edu. Contact Cailin Crowe at ccrowe01@saintmarys.edu read more

FDA Advisory Panel Votes In Favor Of Pfizer’s Coronavirus Vaccine

first_imgPfizer Image.WASHINGTON – The U.S. Food and Drug Administration’s panel of outside advisors voted the Pfizer COVID-19 vaccine benefits outweigh its risk for use in individuals 16 years of age and older, effectively endorsing Pfizer’s Coronavirus vaccine for emergency use authorization approval by the FDA in the United States.The FDA is expected to follow the recommendation issued Thursday by its expert advisers. A final FDA decision is expected within days.The panel called Vaccines and Related Biological Products Advisory Committee consists of independent external experts. The FDA released its review of the vaccine earlier this week, ahead of the Thursday meeting.Thursday afternoon, the panel began discussing the voting question: “Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine outweigh its risks for use in individuals 16 years of age and older?” 17 of the panel members voted in favor of the question, four voted against and one person abstained from voting.Once the vaccine is cleared, Pfizer has said it has an ethical responsibility to tell participants if the vaccine is available to them outside of the trial. It has asked the FDA to allow it to give the vaccine to volunteers who had been in the placebo group that request it.The concern, expressed by both the FDA and members of the advisory panel, is that “unblinding” the trial will make it harder to continue collecting data on long-term safety and effectiveness, and would make it more challenging for companies still testing vaccines to conduct blinded trials, in which people do not know if they got the experimental vaccine or a placebo.Some vaccine trial participants have complained of sore arms and minor aches and pains. Doctors in the U.K. report two vaccine recipients – who both suffer from severe allergies – had allergic reactions to the vaccine. British regulators are now advising those with severe allergic reactions to avoid being vaccinated. It’s not yet clear what caused the reactions.FDA Commissioner Steven Hahn, ahead of Thursday’s meeting, said the agency was carefully reviewing all the data on Pfizer’s vaccine, including potential allergic reactions following the UK warning. Share:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to email this to a friend (Opens in new window)last_img read more